Aspargo Labs

Aspargo Labs, Inc., founded in 2019, formerly known as Aspargo Laboratories, Inc., is headquartered in New York City, New York, USA, with 11 full-time employees. Aspargo Labs is a developer of oral spray products. The company's initial candidate product is a proprietary oral suspension spray containing sildenafil citrate (the active ingredient in Viagra) for the treatment of erectile dysfunction. The spray formulation offers convenient administration, flexible dose titration, and accessibility for patients with swallowing difficulties. Aspargo combines its innovative science and technology to develop patient-centered solutions and medications.